Review ArticleReview Article
Open Access

Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance

Xuesong Feng and Mingqian Lu
Saudi Medical Journal July 2017, 38 (7) 685-690; DOI: https://doi.org/10.15537/smj.2017.7.19372

References

  1. ↵
    1. Adorno-Cruz V,
    2. Kibria G,
    3. Liu X,
    4. Doherty M,
    5. Junk DJ,
    6. Guan D,
    7. et al.
    (2015) Cancer stem cells:targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Cancer Res 75:924–929.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Teodorczyk M,
    2. Kleber S,
    3. Wollny D,
    4. Sefrin JP,
    5. Aykut B,
    6. Mateos A,
    7. et al.
    (2015) CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma. Cell Death Differ 22:1192–1202.
    OpenUrl
  3. ↵
    1. Goel H L,
    2. Gritsko T,
    3. Pursell B,
    4. Chang C,
    5. Shultz LD,
    6. Greiner DL,
    7. et al.
    (2014) Regulated splicing of the alpha6 integrin cytoplasmic domain determines the fate of breast cancer stem cells. Cell Rep 7:747–761.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Koyama-Nasu R,
    2. Haruta R,
    3. Nasu-Nishimura Y,
    4. Taniue K,
    5. Katou Y,
    6. Shirahige K,
    7. et al.
    (2014) The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Oncogene 33:2236–2244.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Drilon A,
    2. Rekhtman N,
    3. Ladanyi M,
    4. Paik P
    (2012) Squamous-cell carcinomas of the lung:emerging biology, controversies, and the promise of targeted therapy. Lancet Oncol 13:e418–e426.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Lengerke C,
    2. Fehm T,
    3. Kurth R,
    4. Neubauer H,
    5. Scheble V,
    6. Müller F,
    7. et al.
    (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11:42.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Power D G,
    2. Kelsen D P,
    3. Shah MA
    (2010) Advanced gastric cancer--slow but steady progress. Cancer Treat Rev 36:384–392.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Herreros-Villanueva M,
    2. Zhang J S,
    3. Koenig A,
    4. Abel EV,
    5. Smyrk TC,
    6. Bamlet WR,
    7. et al.
    (2013) SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2:e61.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Neumann J,
    2. Bahr F,
    3. Horst D,
    4. Kriegl L,
    5. Engel J,
    6. Luque RM,
    7. et al.
    (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11:518.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Guzel E,
    2. Karatas O F,
    3. Duz M B,
    4. Solak M,
    5. Ittmann M,
    6. Ozen M
    (2014) Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer. Prostate 74:1498–1505.
    OpenUrl
  11. ↵
    1. Ren Z H,
    2. Zhang C P,
    3. Ji T
    (2016) Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncol Lett 11:1973–1979.
    OpenUrl
  12. ↵
    1. Lee SH,
    2. Oh SY,
    3. Do SI,
    4. Lee HJ,
    5. Kang HJ,
    6. Rho YS,
    7. et al.
    (2014) SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma. Br J Cancer 111:2122–2130.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Maier S,
    2. Wilbertz T,
    3. Braun M,
    4. Scheble V,
    5. Reischl M,
    6. Mikut R,
    7. et al.
    (2011) SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol 42:1078–1088.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Kokalj VN,
    2. Cizmarevic B,
    3. Zagorac A,
    4. Zagradišnik B,
    5. Lanišnik B
    (2014) An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas. Mol Cytogenet 7:5.
    OpenUrl
  15. ↵
    1. Leis O,
    2. Eguiara A,
    3. Lopez-Arribillaga E,
    4. Alberdi MJ,
    5. Hernandez-Garcia S,
    6. Elorriaga K,
    7. et al.
    (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31:1354–1365.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Kaufhold S,
    2. Garban H,
    3. Bonavida B
    (2016) Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res 35:84.
    OpenUrl
  17. ↵
    1. Kelberman D,
    2. Rizzoti K,
    3. Avilion A,
    4. Bitner-Glindzicz M,
    5. Cianfarani S,
    6. Collins J,
    7. et al.
    (2006) Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest 116:2442–2455.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Fang WT,
    2. Fan CC,
    3. Li SM,
    4. Jang TH,
    5. Lin HP,
    6. Shih NY,
    7. et al.
    (2014) Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. Int J Cancer 135:809–819.
    OpenUrl
  19. ↵
    1. Gangemi R M,
    2. Griffero F,
    3. Marubbi D,
    4. Perera M,
    5. Capra MC,
    6. Malatesta P,
    7. et al.
    (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27:40–48.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Yang N,
    2. Hui L,
    3. Wang Y,
    4. Yang H,
    5. Jiang X
    (2014) SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep 31:2651–2659.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Rodriguez-Pinilla S M,
    2. Sarrio D,
    3. Moreno-Bueno G,
    4. Rodriguez-Gil Y,
    5. Martinez MA,
    6. Hernandez L,
    7. et al.
    (2007) Sox2:a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 20:474–481.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Lengerke C,
    2. Fehm T,
    3. Kurth R,
    4. Neubauer H,
    5. Scheble V,
    6. Müller F,
    7. et al.
    (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11:42.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Zheng Y,
    2. Qin B,
    3. Li F,
    4. Xu S,
    5. Wang S,
    6. Li L
    (2015) Clinicopathological significance of Sox2 expression in patients with breast cancer:a meta-analysis. Int J Clin Exp Med 8:22382–22392.
    OpenUrl
  24. ↵
    1. Huang Y H,
    2. Luo M H,
    3. Ni Y B,
    4. Tsang JY,
    5. Chan SK,
    6. Lui PC,
    7. et al.
    (2014) Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases. Histopathology 64:494–503.
    OpenUrlPubMed
  25. ↵
    1. Perou C M,
    2. Sorlie T,
    3. Eisen M B,
    4. van de Rijn M,
    5. Jeffrey SS,
    6. Rees CA,
    7. et al.
    (2000) Molecular portraits of human breast tumours. Nature 406:747–752.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Chen Y,
    2. Shi L,
    3. Zhang L,
    4. Li R,
    5. Liang J,
    6. Yu W,
    7. et al.
    (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283:17969–17978.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Mou W,
    2. Xu Y,
    3. Ye Y,
    4. Chen S,
    5. Li X,
    6. Gong K,
    7. et al.
    (2015) Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. Cancer Lett 358:115–123.
    OpenUrl
  28. ↵
    1. Li X,
    2. Xu Y,
    3. Chen Y,
    4. Chen S,
    5. Jia X,
    6. Sun T,
    7. et al.
    (2013) SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/beta-catenin signal network. Cancer Lett 336:379–389.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Shima H,
    2. Kutomi G,
    3. Satomi F,
    4. Maeda H,
    5. Hirohashi Y,
    6. Hasegawa T,
    7. et al.
    (2016) SOX2 and ALDH1 as predictors of operable breast cancer. Anticancer Res 36:2945–2953.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Michifuri Y,
    2. Hirohashi Y,
    3. Torigoe T,
    4. Miyazaki A,
    5. Kobayashi J,
    6. Sasaki T,
    7. et al.
    (2012) High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int 62:684–689.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Han Zenglei,
    2. Wang Lina,
    3. Kong Qingnuan,
    4. WEI Hongjun,
    5. CHEN Hua,
    6. HUANG Weiqing
    (2015) The relationship between lymphangiogenesis and SOX2 and vascular endothelial growth factor-C in breast cancer. Chinese Medicine Review (10):23–26.
  32. ↵
    1. Wu F,
    2. Ye X,
    3. Wang P,
    4. Jung K,
    5. Wu C,
    6. Douglas D,
    7. et al.
    (2013) Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity. BMC Cancer 13:317.
    OpenUrl
  33. ↵
    1. Han Zenglei,
    2. Yang Yanhua,
    3. Kong Qingnuan,
    4. WEI Hongjun,
    5. CHEN Hua,
    6. HUANG Weiqing
    (2016) The relationship between SOX2 expression and angiogenesis in breast cancer and its significance. Chinese Journal of Diagnostic Pathology (01):47–49.
  34. ↵
    1. Li X,
    2. Chen S,
    3. Sun T,
    4. Xu Y,
    5. Chen Y,
    6. Liu Y,
    7. et al.
    (2014) The transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancers. Clin Lab 60:909–918.
    OpenUrl
  35. ↵
    1. Sun Y,
    2. Zhang R,
    3. Wang M,
    4. Zhang Y,
    5. Qi J,
    6. Li J
    (2012) SOX2 autoantibodies as noninvasive serum biomarker for breast carcinoma. Cancer Epidemiol Biomarkers Prev 21:2043–2047.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Schaefer T,
    2. Wang H,
    3. Mir P,
    4. Konantz M,
    5. Pereboom TC,
    6. Paczulla AM,
    7. et al.
    (2015) Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget 6:43540–43556.
    OpenUrl
  37. ↵
    1. Liu K,
    2. Xie F,
    3. Gao A,
    4. Zhang R,
    5. Zhang L,
    6. Xiao Z,
    7. et al.
    (2017) SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Mol Cancer 16:62.
    OpenUrlCrossRef
  38. ↵
    1. Finicelli M,
    2. Benedetti G,
    3. Squillaro T,
    4. Pistilli B,
    5. Marcellusi A,
    6. Mariani P,
    7. et al.
    (2014) Expression of stemness genes in primary breast cancer tissues:the role of SOX2 as a prognostic marker for detection of early recurrence. Oncotarget 5:9678–9688.
    OpenUrl
  39. ↵
    1. Piva M,
    2. Domenici G,
    3. Iriondo O,
    4. Rábano M,
    5. Simões BM,
    6. Comaills V,
    7. et al.
    (2014) Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med 6:66–79.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section